Orajel for Cold Sores
Natural health product licensed in Canada
- Licence holder
- Church & Dwight Canada Corp.
- NPN or DIN-HM
- 80082718
- Status
- Inactive licence
- Licence date
- 26 January 2018
- Revision date
- Not provided
- Form
- Liquide
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Acide 4-aminobenzoïque, Ester d'éthyle Source : Benzocaine | 5 Pour cent |
Non-medicinal ingredients
Alcool isopropylique, Chlorure de benzalkonium, Eau
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et enfants | minimum: 2 years | 1 Portion(s) | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
For the temporary relief of pain associated with cold sores/fever blister/oral herpes.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
If the following symptoms appear: weakness, confusion, headache, difficulty breathing and/or pale, gray or blue coloured skin, stop use and consult a health care practitioner. These symptoms may be signs of methemoglobinemia, a rare disorder, which may appear up to 2 hours after use. If allergic to benzocaine, do not use this product.
- Précautions et mises en garde
For external use only. Flammable, keep away from fire or flame. Avoid contact with eyes. If this occurs, immediately flush thoroughly with water. Keep out of reach of children. If symptoms do not improve within 7 days, irritation, pain or redness persists or worsens, or swelling, rash or fever develops, consult health care practitioner promptly. If you are pregnant or breastfeeding, consult a health care practitioner. In case of overdose or accidental ingestion, call a Poison Control Center or medical help right away.
- Effets indésirables connus
Hypersensitivity/allergy is known to occur. In such a case, discontinue use.
Source
Official Health Canada record, licence 80082718
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.